FLUOROMETHOLONE

FLUOROMETHOLONE was reported 3265 times

FLUOROMETHOLONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 75 0.3275
1 SWOLLEN JOINT COUNT 47 0.1880
2 LENTICULAR INJURY 3 0.1765
3 DELLEN 2 0.1176
4 GIANT PAPILLARY CONJUNCTIVITIS 4 0.0800
5 CONJUNCTIVAL SCAR 12 0.0795
6 LUPUS VULGARIS 71 0.0563
7 ACQUIRED PORPHYRIA 4 0.0563
8 CORNEAL ULCER 3 0.0517
9 KERATITIS VIRAL 2 0.0488
10 DISORDER OF GLOBE 2 0.0488
11 KERATOPLASTY 2 0.0476
12 PORPHYRIA ACUTE 63 0.0439
13 KERATITIS FUNGAL 9 0.0433
14 INFECTIVE KERATITIS 3 0.0423
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 86 0.0415
16 CORNEAL NEOVASCULARISATION 10 0.0405
17 AUTOPHONY 3 0.0400
18 DEEP VEIN THROMBOSIS POSTOPERATIVE 79 0.0394
19 DISLOCATION OF VERTEBRA 86 0.0377
20 RETINITIS 64 0.0370
21 X-RAY ABNORMAL 61 0.0341
22 BLADDER CYST 5 0.0309
23 PERIORBITAL INFLAMMATION 7 0.0303
24 CORNEAL GRAFT REJECTION 6 0.0286
25 SCLERAL THINNING 3 0.0283
26 FACET JOINT SYNDROME 87 0.0267
27 BONE EROSION 89 0.0251
28 CORNEAL IRRITATION 2 0.0250
29 INCISION SITE PRURITUS 2 0.0238
30 CORNEAL PERFORATION 15 0.0238
31 EYE INFECTION VIRAL 7 0.0218
32 ANTIPHOSPHOLIPID ANTIBODIES 4 0.0205
33 CATARACT CORTICAL 3 0.0201
34 CORNEAL EXFOLIATION 2 0.0196
35 CORNEAL OPERATION 2 0.0194
36 SYMBLEPHARON 5 0.0192
37 SWOLLEN JOINT COUNT INCREASED 61 0.0191
38 OPHTHALMIC HERPES SIMPLEX 11 0.0191
39 KERATITIS BACTERIAL 3 0.0184
40 CORNEAL SCAR 9 0.0179
41 JOINT TUBERCULOSIS 2 0.0179
42 PERIORBITAL PAIN 15 0.0177
43 MATERNAL EXPOSURE TIMING UNSPECIFIED 63 0.0168
44 CORNEAL DYSTROPHY 7 0.0167
45 CORNEAL EROSION 9 0.0167
46 CORNEAL DEGENERATION 4 0.0165
47 PERIPHERAL VENOUS DISEASE 67 0.0164
48 KERATOCONUS 6 0.0160
49 RHEUMATIC FEVER 66 0.0148
50 OCULAR ROSACEA 3 0.0148
51 DUODENAL ULCER PERFORATION 109 0.0146
52 BREAST CANCER STAGE III 94 0.0145
53 OCULAR SURFACE DISEASE 4 0.0142
54 C-REACTIVE PROTEIN ABNORMAL 88 0.0137
55 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 95 0.0132
56 DRUG TOLERANCE DECREASED 37 0.0132
57 EAR INFECTION VIRAL 2 0.0125
58 CORNEAL DEPOSITS 9 0.0121
59 HYPOPYON 10 0.0121
60 AUTOIMMUNE DISORDER 116 0.0119
61 CORNEAL THINNING 3 0.0117
62 CERVIX CARCINOMA RECURRENT 2 0.0112
63 HELICOBACTER INFECTION 115 0.0112
64 KERATOCONJUNCTIVITIS SICCA 4 0.0109
65 RHEUMATOID FACTOR POSITIVE 62 0.0107
66 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 69 0.0106
67 FOLLICULITIS 108 0.0103
68 PUNCTATE KERATITIS 9 0.0098
69 CORNEAL DISORDER 21 0.0096
70 CORNEAL OPACITY 13 0.0095
71 LENTICULAR OPACITIES 4 0.0092
72 BENDOPNOEA 2 0.0091
73 EYELID INFECTION 4 0.0091
74 EXOSTOSIS 82 0.0090
75 GRIP STRENGTH DECREASED 79 0.0090
76 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 5 0.0089
77 ECTROPION 3 0.0089
78 EYELID PAIN 18 0.0088
79 CONJUNCTIVITIS BACTERIAL 3 0.0088
80 C-REACTIVE PROTEIN 8 0.0086
81 CORNEAL EPITHELIUM DEFECT 5 0.0086
82 MUSCLE INJURY 71 0.0086
83 KERATITIS 26 0.0085
84 KERATIC PRECIPITATES 4 0.0084
85 BURSITIS 101 0.0083
86 HYPERCHOLESTEROLAEMIA 76 0.0079
87 HAND DEFORMITY 98 0.0075
88 WALKING AID USER 49 0.0074
89 FOOT DEFORMITY 82 0.0074
90 LIP DRY 67 0.0074
91 CHOROIDAL DETACHMENT 4 0.0072
92 VITREOUS OPACITIES 6 0.0071
93 PEMPHIGUS 84 0.0067
94 EAR INFECTION FUNGAL 2 0.0066
95 BONE CONTUSION 6 0.0065
96 CORNEAL INFILTRATES 2 0.0064
97 CONJUNCTIVAL HYPERAEMIA 22 0.0062
98 INTRAOCULAR LENS IMPLANT 3 0.0061
99 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
100 SCLERAL HYPERAEMIA 4 0.0059
101 WOUND INFECTION 64 0.0058
102 LUPUS-LIKE SYNDROME 53 0.0058
103 INTRAOCULAR PRESSURE TEST ABNORMAL 4 0.0057
104 DYSPLASTIC NAEVUS 2 0.0055
105 CONJUNCTIVITIS ALLERGIC 8 0.0054
106 FOREIGN BODY SENSATION IN EYES 34 0.0053
107 GLOSSODYNIA 118 0.0053
108 BONE TUBERCULOSIS 2 0.0052
109 OCULAR HYPERTENSION 10 0.0051
110 PERICARDITIS 86 0.0051
111 CORNEAL TRANSPLANT 4 0.0051
112 CATARACT SUBCAPSULAR 3 0.0049
113 JOINT RANGE OF MOTION DECREASED 65 0.0048
114 LIVE BIRTH 39 0.0047
115 VULVAL DISORDER 3 0.0045
116 HEPATIC CIRRHOSIS 85 0.0045
117 CONGENITAL ANOMALY 35 0.0045
118 TREATMENT FAILURE 372 0.0045
119 CORNEAL OEDEMA 10 0.0045
120 SCIATICA 70 0.0044
121 CORNEAL ABRASION 6 0.0044
122 SERONEGATIVE ARTHRITIS 5 0.0044
123 SYNOVITIS 78 0.0043
124 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 72 0.0042
125 BLEPHARITIS 17 0.0042
126 EYE PAIN 236 0.0042
127 EYELID RASH 4 0.0041
128 ULCERATIVE KERATITIS 11 0.0040
129 INTRAOCULAR PRESSURE INCREASED 51 0.0040
130 IRITIS 12 0.0039
131 OCULAR DISCOMFORT 44 0.0039
132 CONJUNCTIVAL OEDEMA 4 0.0039
133 IRRITABLE BOWEL SYNDROME 83 0.0039
134 INJURY CORNEAL 2 0.0038
135 HYPHAEMA 2 0.0038
136 EYELID EXFOLIATION 3 0.0038
137 FIBROMYALGIA 91 0.0037
138 OBESITY 58 0.0036
139 SEPTIC EMBOLUS 3 0.0036
140 EYE INFECTION BACTERIAL 2 0.0036
141 WEIGHT FLUCTUATION 37 0.0035
142 EYE ULCER 2 0.0035
143 EYELID DISORDER 8 0.0035
144 EYELID MARGIN CRUSTING 10 0.0035
145 ENDOCRINE OPHTHALMOPATHY 3 0.0035
146 INFUSION SITE DISCOLOURATION 3 0.0034
147 EYE BURNS 2 0.0034
148 PULMONARY FIBROSIS 65 0.0034
149 INFUSION SITE INDURATION 5 0.0034
150 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
151 EAR INFECTION 89 0.0033
152 IMPAIRED HEALING 109 0.0033
153 WOUND 91 0.0033
154 PRODUCT APPEARANCE CONFUSION 3 0.0032
155 PRODUCT DELIVERY MECHANISM ISSUE 17 0.0032
156 DUST ALLERGY 3 0.0031
157 EYE IRRITATION 175 0.0030
158 EYE INFLAMMATION 29 0.0030
159 FREQUENT BOWEL MOVEMENTS 82 0.0030
160 LOWER LIMB FRACTURE 58 0.0030
161 CATARACT NUCLEAR 2 0.0030
162 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
163 EYE DISCHARGE 30 0.0029
164 FUSARIUM INFECTION 2 0.0029
165 LIVER INJURY 70 0.0028
166 EYELID IRRITATION 7 0.0028
167 SUPERFICIAL INJURY OF EYE 3 0.0027
168 INFUSION SITE HAEMORRHAGE 9 0.0027
169 DELIRIUM 94 0.0027
170 PHOTOPHOBIA 50 0.0027
171 ASTIGMATISM 4 0.0026
172 PRESCRIBED OVERDOSE 51 0.0026
173 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
174 IRIDOCYCLITIS 8 0.0025
175 EYELID FUNCTION DISORDER 2 0.0025
176 KERATOPATHY 4 0.0025
177 SCLERITIS 4 0.0025
178 SYSTEMIC LUPUS ERYTHEMATOSUS 86 0.0024
179 INSTILLATION SITE PAIN 6 0.0024
180 ERYTHEMA OF EYELID 13 0.0024
181 SWELLING OF EYELID 15 0.0024
182 LACRIMATION INCREASED 71 0.0023
183 INFUSION SITE REACTION 7 0.0023
184 ABNORMAL SENSATION IN EYE 10 0.0023
185 EYE INJURY 7 0.0023
186 OCULAR HYPERAEMIA 108 0.0023
187 LIP EXFOLIATION 3 0.0023
188 ARTHROPATHY 124 0.0022
189 TYPE 2 DIABETES MELLITUS 75 0.0022
190 SPONDYLITIS 8 0.0022
191 BLOOD CHOLESTEROL INCREASED 101 0.0022
192 ROSACEA 10 0.0021
193 KLEBSIELLA BACTERAEMIA 2 0.0021
194 HIP ARTHROPLASTY 32 0.0021
195 FOREIGN BODY IN EYE 2 0.0021
196 PREGNANCY 41 0.0020
197 LABORATORY TEST ABNORMAL 60 0.0020
198 LOWER RESPIRATORY TRACT INFECTION 92 0.0020
199 STEROID DIABETES 3 0.0020
200 PSORIATIC ARTHROPATHY 81 0.0020
201 CONJUNCTIVITIS 37 0.0020
202 JOINT DISLOCATION 21 0.0020
203 NIGHT SWEATS 64 0.0020
204 COLITIS ULCERATIVE 88 0.0020
205 CHEST INJURY 4 0.0019
206 DISCOMFORT 116 0.0019
207 BLISTER 106 0.0019
208 ILL-DEFINED DISORDER 114 0.0019
209 DRY EYE 93 0.0019
210 AMAUROSIS FUGAX 2 0.0019
211 SKIN DISCOMFORT 5 0.0019
212 INSTILLATION SITE REACTION 2 0.0018
213 DEAFNESS NEUROSENSORY 6 0.0018
214 ARTHROPOD STING 3 0.0018
215 ROAD TRAFFIC ACCIDENT 75 0.0018
216 CALCINOSIS 4 0.0018
217 RECTAL ABSCESS 3 0.0018
218 ENTEROBACTER INFECTION 3 0.0018
219 PRODUCT CONTAINER ISSUE 15 0.0017
220 SPINAL FUSION SURGERY 7 0.0017
221 OSTEOARTHRITIS 73 0.0017
222 WHITE BLOOD CELL COUNT INCREASED 66 0.0017
223 INSTILLATION SITE IRRITATION 2 0.0017
224 EYE SWELLING 62 0.0017
225 EMBOLISM ARTERIAL 2 0.0017
226 GLAUCOMA 32 0.0017
227 INFUSION RELATED REACTION 109 0.0016
228 PROSTATITIS 5 0.0016
229 CONTRAST MEDIA ALLERGY 3 0.0016
230 DYSCHEZIA 5 0.0016
231 RECTAL HAEMORRHAGE 70 0.0016
232 RED BLOOD CELL SEDIMENTATION RATE INCREASED 18 0.0016
233 STOMATITIS 98 0.0016
234 EYE PRURITUS 54 0.0016
235 ALLERGY TO CHEMICALS 2 0.0016
236 HYPERPARATHYROIDISM SECONDARY 4 0.0016
237 CYSTOID MACULAR OEDEMA 3 0.0016
238 PERIORBITAL SWELLING 9 0.0016
239 LUNG DISORDER 78 0.0016
240 LIVER DISORDER 70 0.0016
241 RETINAL OEDEMA 3 0.0016
242 MATERNAL EXPOSURE DURING PREGNANCY 138 0.0015
243 APHTHOUS ULCER 12 0.0015
244 INFUSION SITE ERYTHEMA 13 0.0015
245 KNEE ARTHROPLASTY 32 0.0015
246 INFLAMMATION 78 0.0015
247 MENINGITIS 10 0.0015
248 HEPATIC ENZYME INCREASED 102 0.0015
249 DRY MOUTH 119 0.0015
250 EFFUSION 2 0.0015
251 OSTEOPOROSIS 60 0.0015
252 IMMUNOGLOBULINS DECREASED 2 0.0015
253 RHINALGIA 4 0.0015
254 DISCHARGE 2 0.0014
255 DEATH NEONATAL 2 0.0014
256 ONYCHOMADESIS 6 0.0014
257 AMNESIA 93 0.0014
258 EYE INFECTION 16 0.0014
259 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
260 MUSCULOSKELETAL PAIN 74 0.0014
261 CONNECTIVE TISSUE DISORDER 2 0.0014
262 PRODUCT CONTAMINATION 5 0.0014
263 INJECTION SITE HYPOAESTHESIA 2 0.0014
264 FACIAL BONES FRACTURE 5 0.0014
265 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
266 FEELING HOT 85 0.0014
267 HYPERTONIC BLADDER 4 0.0014
268 PANCREATITIS 73 0.0014
269 ADENOVIRUS INFECTION 4 0.0014
270 GASTROINTESTINAL DISORDER 122 0.0014
271 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
272 APRAXIA 2 0.0013
273 JOINT STIFFNESS 35 0.0013
274 ENDOPHTHALMITIS 8 0.0013
275 UVEITIS 18 0.0013
276 HAEMATOCRIT INCREASED 3 0.0013
277 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
278 PRESCRIBED UNDERDOSE 26 0.0013
279 THYROID MASS 5 0.0013
280 ENCEPHALITIS 9 0.0013
281 INFUSION SITE INFECTION 3 0.0013
282 OEDEMA 70 0.0013
283 JOINT DESTRUCTION 2 0.0013
284 BLEPHAROSPASM 8 0.0013
285 RESPIRATORY DISORDER 38 0.0013
286 PUSTULE 3 0.0013
287 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
288 SKIN EROSION 4 0.0012
289 ARTHRITIS 97 0.0012
290 ENTEROCOLITIS 7 0.0012
291 MADAROSIS 14 0.0012
292 EYELID OEDEMA 14 0.0012
293 INJURY 84 0.0012
294 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
295 CONTUSION 114 0.0012
296 CATARACT OPERATION 7 0.0012
297 REGURGITATION 4 0.0012
298 EYE DISORDER 38 0.0012
299 HYPOPITUITARISM 2 0.0011
300 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 55 0.0011
301 INFUSION SITE DISCHARGE 2 0.0011
302 BURNS SECOND DEGREE 2 0.0011
303 ASTHMA 128 0.0011
304 WHEEZING 67 0.0011
305 PROTEIN TOTAL INCREASED 3 0.0011
306 HEPATOMEGALY 11 0.0011
307 GINGIVITIS 6 0.0011
308 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
309 ESSENTIAL HYPERTENSION 2 0.0011
310 ASTHENOPIA 6 0.0011
311 PHOTOSENSITIVITY REACTION 18 0.0011
312 RETINAL DETACHMENT 10 0.0011
313 NEPHROGENIC ANAEMIA 5 0.0011
314 PROTEIN TOTAL DECREASED 4 0.0011
315 MOBILITY DECREASED 75 0.0010
316 NAIL DISORDER 9 0.0010
317 PROSTATOMEGALY 4 0.0010
318 ONYCHOCLASIS 7 0.0010
319 HYPERAEMIA 2 0.0010
320 PNEUMONIA FUNGAL 4 0.0010
321 SINUSITIS 102 0.0010
322 REBOUND ACID HYPERSECRETION 3 0.0010
323 CATARACT 59 0.0010
324 DIVERTICULUM 7 0.0010
325 DYSLIPIDAEMIA 5 0.0010
326 IMPAIRED SELF-CARE 2 0.0010
327 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
328 VISUAL IMPAIRMENT 117 0.0009
329 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
330 VISUAL ACUITY REDUCED 31 0.0009
331 HYPERPHOSPHATAEMIA 2 0.0009
332 VISION BLURRED 127 0.0009
333 HORDEOLUM 4 0.0009
334 THERAPY NON-RESPONDER 41 0.0009
335 CLOSTRIDIUM TEST POSITIVE 2 0.0009
336 DYSPEPSIA 89 0.0009
337 BLOOD URINE PRESENT 17 0.0009
338 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
339 TASTE DISORDER 18 0.0009
340 ULCER HAEMORRHAGE 6 0.0009
341 HEPATIC CYST 3 0.0009
342 HAEMOGLOBIN INCREASED 4 0.0009
343 PUSTULAR PSORIASIS 3 0.0009
344 EYE OPERATION 4 0.0009
345 RHEUMATOID ARTHRITIS 97 0.0009
346 INFUSION SITE PAIN 11 0.0009
347 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
348 RETINAL HAEMORRHAGE 6 0.0008
349 SWELLING 78 0.0008
350 VISUAL FIELD DEFECT 6 0.0008
351 SKIN LACERATION 9 0.0008
352 ARTHROPOD BITE 6 0.0008
353 ORGANISING PNEUMONIA 4 0.0008
354 GENERAL PHYSICAL HEALTH DETERIORATION 93 0.0008
355 CORONARY ARTERY STENOSIS 4 0.0008
356 SNORING 3 0.0008
357 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
358 TOOTH ABSCESS 8 0.0008
359 FEMORAL NECK FRACTURE 4 0.0008
360 AORTIC ARTERIOSCLEROSIS 2 0.0008
361 EXPOSURE DURING PREGNANCY 48 0.0008
362 PERIORBITAL OEDEMA 4 0.0008
363 OPTIC NEURITIS 7 0.0008
364 EPIGASTRIC DISCOMFORT 3 0.0008
365 MUSCULAR WEAKNESS 87 0.0008
366 JOINT SWELLING 92 0.0008
367 HYPERSENSITIVITY 141 0.0008
368 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
369 MUSCULOSKELETAL STIFFNESS 66 0.0008
370 GASTROINTESTINAL STROMAL TUMOUR 2 0.0008
371 HEPATIC STEATOSIS 14 0.0008
372 CONFUSIONAL STATE 121 0.0007
373 ANAL FISSURE 4 0.0007
374 ABDOMINAL DISCOMFORT 125 0.0007
375 HYPOAESTHESIA 109 0.0007
376 SPINAL COMPRESSION FRACTURE 6 0.0007
377 INFECTION 105 0.0007
378 CHOKING SENSATION 4 0.0007
379 BREAST CANCER STAGE II 6 0.0007
380 C-REACTIVE PROTEIN INCREASED 26 0.0007
381 ENDOTRACHEAL INTUBATION 2 0.0007
382 VITREOUS FLOATERS 7 0.0007
383 ABSCESS LIMB 3 0.0007
384 CHEST PAIN 130 0.0007
385 PERIPHERAL SWELLING 108 0.0007
386 PRODUCT USE COMPLAINT 11 0.0007
387 FIBULA FRACTURE 2 0.0007
388 DIVERTICULUM INTESTINAL 3 0.0007
389 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
390 MIGRAINE 65 0.0007
391 BLINDNESS TRANSIENT 5 0.0007
392 RHINITIS ALLERGIC 3 0.0007
393 EAR PAIN 13 0.0007
394 MYOSITIS 6 0.0007
395 SUSPECTED OFF LABEL USE 3 0.0007
396 TOOTHACHE 12 0.0007
397 ADRENAL INSUFFICIENCY 8 0.0007
398 GAIT INABILITY 22 0.0007
399 UNDERDOSE 48 0.0007
400 ALOPECIA 129 0.0007
401 SLEEP DISORDER 46 0.0007
402 IRON DEFICIENCY ANAEMIA 6 0.0006
403 PHARYNGITIS 8 0.0006
404 ERYTHEMA MULTIFORME 6 0.0006
405 PRE-EXISTING CONDITION IMPROVED 4 0.0006
406 MULTIPLE ALLERGIES 5 0.0006
407 SEASONAL ALLERGY 9 0.0006
408 SKIN ABRASION 3 0.0006
409 PHOTOPSIA 4 0.0006
410 SLEEP APNOEA SYNDROME 12 0.0006
411 NASOPHARYNGITIS 115 0.0006
412 CUSHINGOID 2 0.0006
413 ROTATOR CUFF SYNDROME 8 0.0006
414 RASH VESICULAR 3 0.0006
415 MOUTH ULCERATION 13 0.0006
416 DERMATITIS CONTACT 7 0.0006
417 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
418 LIVER FUNCTION TEST INCREASED 13 0.0006
419 HYPERTENSION 128 0.0006
420 GAIT DISTURBANCE 115 0.0006
421 DECREASED APPETITE 138 0.0006
422 OEDEMA PERIPHERAL 72 0.0006
423 MEMORY IMPAIRMENT 81 0.0006
424 DEPRESSION 134 0.0006
425 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
426 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
427 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
428 HAIR GROWTH ABNORMAL 4 0.0006
429 BASAL CELL CARCINOMA 9 0.0006
430 EAR PRURITUS 2 0.0006
431 SENSITIVITY TO WEATHER CHANGE 3 0.0006
432 MUSCLE SPASTICITY 7 0.0006
433 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
434 POLYARTHRITIS 3 0.0006
435 FACIAL PARESIS 2 0.0006
436 MUSCLE SPASMS 103 0.0006
437 FACIAL PAIN 5 0.0006
438 INJECTION SITE DISCHARGE 3 0.0006
439 END STAGE RENAL DISEASE 10 0.0005
440 HYPERKERATOSIS 3 0.0005
441 AMYLASE INCREASED 2 0.0005
442 HYPOPHOSPHATAEMIA 4 0.0005
443 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
444 ABDOMINAL PAIN UPPER 111 0.0005
445 DIPLOPIA 14 0.0005
446 DRUG INTOLERANCE 52 0.0005
447 ABDOMINAL PAIN 125 0.0005
448 CONDITION AGGRAVATED 163 0.0005
449 ORAL PAIN 12 0.0005
450 SNEEZING 12 0.0005
451 DERMATITIS 11 0.0005
452 PARAESTHESIA 82 0.0005
453 HAEMORRHOIDS 10 0.0005
454 HYPERTRIGLYCERIDAEMIA 3 0.0005
455 SWOLLEN TONGUE 16 0.0005
456 SKIN FISSURES 10 0.0005
457 ANXIETY 145 0.0005
458 CANDIDIASIS 2 0.0005
459 INTRACRANIAL ANEURYSM 2 0.0005
460 FEBRILE NEUTROPENIA 33 0.0005
461 BLINDNESS UNILATERAL 7 0.0005
462 FUNGAL SKIN INFECTION 2 0.0005
463 EYELID PTOSIS 5 0.0005
464 WEIGHT INCREASED 110 0.0005
465 BLINDNESS 20 0.0005
466 MENISCUS INJURY 3 0.0005
467 EAR DISCOMFORT 5 0.0005
468 OLIGURIA 3 0.0005
469 SKIN DISORDER 16 0.0005
470 DRUG-INDUCED LIVER INJURY 15 0.0005
471 INFUSION SITE SWELLING 3 0.0005
472 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
473 SCAR 8 0.0005
474 DEVICE OPERATIONAL ISSUE 2 0.0005
475 POOR QUALITY SLEEP 10 0.0005
476 DECREASED ACTIVITY 5 0.0005
477 HERPES SIMPLEX 3 0.0005
478 CHOKING 9 0.0005
479 TENDON DISORDER 3 0.0005
480 BACK INJURY 5 0.0005
481 SOMNAMBULISM 3 0.0005
482 ORAL CANDIDIASIS 6 0.0005
483 SKIN MASS 3 0.0004
484 QUALITY OF LIFE DECREASED 6 0.0004
485 GOUT 8 0.0004
486 ANAL INCONTINENCE 4 0.0004
487 SINUS CONGESTION 6 0.0004
488 OROPHARYNGEAL DISCOMFORT 4 0.0004
489 PRODUCT LABEL ISSUE 3 0.0004
490 URTICARIA 74 0.0004
491 RIB FRACTURE 9 0.0004
492 LYMPHOEDEMA 3 0.0004
493 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
494 LARGE INTESTINE POLYP 3 0.0004
495 ORAL DISCOMFORT 6 0.0004
496 DEFAECATION URGENCY 3 0.0004
497 SQUAMOUS CELL CARCINOMA 4 0.0004
498 DYSPNOEA EXERTIONAL 16 0.0004
499 CHRONIC KIDNEY DISEASE 32 0.0004
500 BLOOD UREA INCREASED 7 0.0004
501 WRIST FRACTURE 5 0.0004
502 INSOMNIA 111 0.0004
503 PYREXIA 144 0.0004
504 ARTHRALGIA 173 0.0004
505 HEMIPARESIS 7 0.0004
506 NOCTURIA 5 0.0004
507 MAJOR DEPRESSION 3 0.0004
508 VITAMIN D DEFICIENCY 4 0.0004
509 CYTOPENIA 5 0.0004
510 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
511 SENSITIVE SKIN 3 0.0004
512 BODY TEMPERATURE DECREASED 4 0.0004
513 SPINAL OPERATION 5 0.0004
514 SKIN HAEMORRHAGE 6 0.0004
515 PNEUMONIA 131 0.0004
516 LIGAMENT SPRAIN 4 0.0004
517 FOOT OPERATION 2 0.0004
518 INJECTION SITE INFLAMMATION 2 0.0004
519 HEPATIC ENZYME ABNORMAL 2 0.0004
520 SPEECH DISORDER 21 0.0004
521 PRURITUS 153 0.0004
522 PRODUCT ADMINISTRATION ERROR 8 0.0004
523 ASTHENIA 148 0.0004
524 PROCEDURAL COMPLICATION 3 0.0004
525 INCREASED UPPER AIRWAY SECRETION 2 0.0004
526 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
527 FOOD ALLERGY 3 0.0004
528 POOR VENOUS ACCESS 4 0.0004
529 FAILURE TO THRIVE 2 0.0004
530 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
531 GASTRITIS 10 0.0004
532 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4 0.0004
533 NASAL DISCOMFORT 3 0.0004
534 BRONCHITIS 28 0.0004
535 HALLUCINATION, AUDITORY 6 0.0004
536 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
537 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
538 BEHAVIOUR DISORDER 2 0.0004
539 CEREBRAL INFARCTION 9 0.0004
540 IMPAIRED GASTRIC EMPTYING 5 0.0004
541 AUTISM SPECTRUM DISORDER 2 0.0004
542 DEAFNESS UNILATERAL 2 0.0004
543 WEIGHT DECREASED 101 0.0004
544 DENTAL CARIES 4 0.0004
545 DERMATITIS ATOPIC 19 0.0004
546 STEVENS-JOHNSON SYNDROME 8 0.0004
547 HYPOMAGNESAEMIA 5 0.0004
548 MASS 5 0.0004
549 FACIAL PARALYSIS 3 0.0004
550 GENERALISED ERYTHEMA 2 0.0004
551 SKIN HYPERPIGMENTATION 3 0.0003
552 HERPES ZOSTER 20 0.0003
553 EXERCISE TOLERANCE DECREASED 2 0.0003
554 HERPES VIRUS INFECTION 2 0.0003
555 RASH 150 0.0003
556 ECZEMA 18 0.0003
557 DECREASED INTEREST 2 0.0003
558 POLLAKIURIA 14 0.0003
559 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
560 PRODUCT USE ISSUE 63 0.0003
561 HEARING IMPAIRED 2 0.0003
562 INTERSTITIAL LUNG DISEASE 16 0.0003
563 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
564 SKIN LESION 9 0.0003
565 EPILEPSY 10 0.0003
566 PNEUMONIA BACTERIAL 3 0.0003
567 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
568 SKIN CANCER 7 0.0003
569 BACTERIAL INFECTION 6 0.0003
570 AGEUSIA 8 0.0003
571 FLANK PAIN 3 0.0003
572 BRAIN FOG 5 0.0003
573 BLOOD SODIUM DECREASED 6 0.0003
574 MALAISE 138 0.0003
575 DIZZINESS 156 0.0003
576 DYSPNOEA 177 0.0003
577 APPLICATION SITE VESICLES 2 0.0003
578 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
579 BACK DISORDER 5 0.0003
580 BRADYPHRENIA 2 0.0003
581 COELIAC DISEASE 3 0.0003
582 TINNITUS 14 0.0003
583 HYPOGAMMAGLOBULINAEMIA 2 0.0003
584 DISABILITY 6 0.0003
585 VIRAL INFECTION 10 0.0003
586 CARDIAC FAILURE ACUTE 2 0.0003
587 OVARIAN CYST 3 0.0003
588 EYE HAEMORRHAGE 4 0.0003
589 CYTOKINE RELEASE SYNDROME 6 0.0003
590 CHOLECYSTITIS CHRONIC 2 0.0003
591 BRONCHIECTASIS 2 0.0003
592 COLITIS ISCHAEMIC 2 0.0003
593 PRODUCT DOSE OMISSION ISSUE 87 0.0003
594 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
595 BODY TEMPERATURE INCREASED 6 0.0003
596 EYE MOVEMENT DISORDER 2 0.0003
597 HEADACHE 183 0.0003
598 ECCHYMOSIS 2 0.0003
599 DIARRHOEA 188 0.0003
600 MEDICATION ERROR 16 0.0003
601 BLOOD PRESSURE INCREASED 44 0.0003
602 FATIGUE 224 0.0003
603 EXTRASYSTOLES 2 0.0003
604 CARPAL TUNNEL SYNDROME 4 0.0003
605 SCRATCH 3 0.0003
606 HEAD INJURY 9 0.0003
607 DUODENAL ULCER 2 0.0003
608 SKIN DISCOLOURATION 13 0.0003
609 LYMPHOCYTE COUNT DECREASED 5 0.0003
610 NO ADVERSE EVENT 51 0.0003
611 FEAR OF INJECTION 2 0.0003
612 BREAST CANCER METASTATIC 3 0.0003
613 ANGINA PECTORIS 8 0.0003
614 IMPAIRED QUALITY OF LIFE 4 0.0003
615 DERMATITIS BULLOUS 2 0.0003
616 HAEMATEMESIS 7 0.0003
617 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
618 GASTROENTERITIS 4 0.0003
619 DRUG RESISTANCE 7 0.0003
620 ILLNESS 28 0.0003
621 RESPIRATORY TRACT INFECTION 7 0.0003
622 IMMUNODEFICIENCY 4 0.0003
623 HEPATIC FUNCTION ABNORMAL 10 0.0003
624 THROAT IRRITATION 12 0.0003
625 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
626 DEPRESSED MOOD 14 0.0003
627 FRACTURE 5 0.0003
628 IMPAIRED DRIVING ABILITY 3 0.0003
629 DRY SKIN 35 0.0003
630 MYOCARDITIS 3 0.0003
631 NEOPLASM 3 0.0003
632 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
633 OFF LABEL USE 228 0.0003
634 ACUTE RESPIRATORY FAILURE 5 0.0003
635 HAEMOLYSIS 2 0.0003
636 ATRIOVENTRICULAR BLOCK 2 0.0003
637 ERUCTATION 5 0.0003
638 CONCUSSION 2 0.0003
639 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
640 HYPOALBUMINAEMIA 2 0.0003
641 SPINAL PAIN 3 0.0003
642 TREATMENT NONCOMPLIANCE 14 0.0003
643 AFFECTIVE DISORDER 2 0.0003
644 FURUNCLE 2 0.0003
645 BLOOD ALBUMIN DECREASED 2 0.0003
646 GINGIVAL PAIN 2 0.0003
647 CYSTITIS 8 0.0003
648 ACCIDENT 3 0.0003
649 BLOOD PRESSURE FLUCTUATION 6 0.0002
650 OXYGEN SATURATION DECREASED 14 0.0002
651 SKIN EXFOLIATION 21 0.0002
652 RHINORRHOEA 16 0.0002
653 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
654 SCHIZOPHRENIA 3 0.0002
655 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
656 FALL 81 0.0002
657 PRODUCT PREPARATION ERROR 5 0.0002
658 HEART RATE INCREASED 24 0.0002
659 APPLICATION SITE IRRITATION 3 0.0002
660 EPISTAXIS 18 0.0002
661 DYSPHONIA 14 0.0002
662 CARDIAC FAILURE 19 0.0002
663 URINARY TRACT INFECTION 40 0.0002
664 CONSTIPATION 51 0.0002
665 MUSCULOSKELETAL DISCOMFORT 4 0.0002
666 SKIN ULCER 6 0.0002
667 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 47 0.0002
668 VOMITING 109 0.0002
669 HYSTERECTOMY 2 0.0002
670 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
671 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
672 PLATELET COUNT INCREASED 3 0.0002
673 ORTHOSTATIC HYPOTENSION 4 0.0002
674 DEAFNESS 6 0.0002
675 DEVICE USE ISSUE 4 0.0002
676 ANHEDONIA 6 0.0002
677 BLOOD CALCIUM INCREASED 2 0.0002
678 TOOTH INFECTION 3 0.0002
679 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
680 SARS-COV-2 TEST POSITIVE 3 0.0002
681 APPLICATION SITE PAIN 5 0.0002
682 HEAD DISCOMFORT 4 0.0002
683 BLOOD PRESSURE DECREASED 15 0.0002
684 TACHYCARDIA 20 0.0002
685 TOOTH DISORDER 5 0.0002
686 HAIR TEXTURE ABNORMAL 3 0.0002
687 ISCHAEMIC STROKE 4 0.0002
688 HAEMOLYTIC ANAEMIA 2 0.0002
689 GASTROINTESTINAL INFECTION 2 0.0002
690 RASH PRURITIC 12 0.0002
691 OSTEOMYELITIS 4 0.0002
692 LIMB INJURY 6 0.0002
693 PAIN 135 0.0002
694 HYPERGLYCAEMIA 8 0.0002
695 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
696 CELLULITIS 11 0.0002
697 HYPOKALAEMIA 10 0.0002
698 DIVERTICULITIS 6 0.0002
699 DYSGEUSIA 16 0.0002
700 HAEMOPTYSIS 6 0.0002
701 HAEMOGLOBIN DECREASED 22 0.0002
702 MIDDLE INSOMNIA 4 0.0002
703 ERYTHEMA 44 0.0002
704 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
705 DEVICE OCCLUSION 3 0.0002
706 ARTERIOSCLEROSIS 2 0.0002
707 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
708 ACNE 16 0.0002
709 BACK PAIN 49 0.0002
710 DYSPHAGIA 20 0.0002
711 EXPIRED PRODUCT ADMINISTERED 7 0.0002
712 PRODUCTIVE COUGH 10 0.0002
713 RASH ERYTHEMATOUS 10 0.0002
714 PRODUCT SUBSTITUTION ISSUE 12 0.0002
715 POST PROCEDURAL COMPLICATION 4 0.0002
716 BALANCE DISORDER 18 0.0002
717 HYPERTHYROIDISM 3 0.0002
718 PRESYNCOPE 5 0.0002
719 NEURALGIA 5 0.0002
720 OROPHARYNGEAL PAIN 19 0.0002
721 COVID-19 36 0.0002
722 INFLAMMATORY BOWEL DISEASE 2 0.0002
723 HOSPICE CARE 2 0.0002
724 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
725 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
726 PRODUCT DOSE OMISSION 13 0.0002
727 HOT FLUSH 15 0.0002
728 HYPOXIA 7 0.0002
729 FULL BLOOD COUNT DECREASED 4 0.0002
730 CORONARY ARTERY DISEASE 6 0.0002
731 BLOOD COUNT ABNORMAL 3 0.0002
732 PRODUCT COMPLAINT 5 0.0002
733 PLATELET COUNT DECREASED 21 0.0002
734 NECK PAIN 11 0.0002
735 ADVERSE EVENT 18 0.0002
736 DEVICE RELATED INFECTION 3 0.0002
737 THERAPY CESSATION 10 0.0002
738 NAUSEA 154 0.0002
739 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
740 FLATULENCE 11 0.0002
741 ANKLE FRACTURE 3 0.0002
742 TENDONITIS 3 0.0002
743 ACUTE MYELOID LEUKAEMIA 3 0.0002
744 RESTLESSNESS 7 0.0002
745 NEUROPATHY PERIPHERAL 18 0.0002
746 RESPIRATORY TRACT CONGESTION 3 0.0002
747 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
748 MULTIPLE SCLEROSIS 9 0.0002
749 SURGERY 11 0.0002
750 NASAL CONGESTION 11 0.0002
751 IMPAIRED WORK ABILITY 4 0.0002
752 ATRIAL FIBRILLATION 18 0.0002
753 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
754 BIPOLAR DISORDER 2 0.0002
755 CEREBROVASCULAR ACCIDENT 31 0.0002
756 DRUG INEFFECTIVE 241 0.0002
757 MULTIPLE FRACTURES 3 0.0002
758 THERAPEUTIC RESPONSE DECREASED 11 0.0002
759 PAIN IN EXTREMITY 53 0.0002
760 CHILLS 21 0.0002
761 ADVERSE DRUG REACTION 16 0.0002
762 BLOOD CALCIUM DECREASED 2 0.0002
763 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
764 CANDIDA INFECTION 3 0.0002
765 CHROMATURIA 4 0.0002
766 PRODUCT QUALITY ISSUE 24 0.0002
767 PAIN IN JAW 5 0.0002
768 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
769 RED BLOOD CELL COUNT DECREASED 5 0.0002
770 HYPERSOMNIA 5 0.0002
771 NEPHROLITHIASIS 8 0.0002
772 SHOCK 4 0.0002
773 HALLUCINATION 13 0.0002
774 RASH MACULAR 6 0.0002
775 HYPERKALAEMIA 6 0.0002
776 SEPSIS 19 0.0002
777 PSYCHOTIC DISORDER 5 0.0002
778 DRUG ERUPTION 3 0.0002
779 SWELLING FACE 11 0.0002
780 BLOOD IRON DECREASED 2 0.0002
781 BACTERAEMIA 2 0.0002
782 BLOOD CREATININE INCREASED 11 0.0002
783 PRODUCT PRESCRIBING ERROR 4 0.0002
784 THERAPY INTERRUPTED 12 0.0002
785 COUGH 47 0.0002
786 HYPERLIPIDAEMIA 2 0.0002
787 RENAL IMPAIRMENT 14 0.0002
788 HEPATITIS C 2 0.0002
789 VERTIGO 10 0.0002
790 ACCIDENTAL OVERDOSE 6 0.0002
791 ABDOMINAL DISTENSION 17 0.0002
792 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
793 HYPERCALCAEMIA 2 0.0002
794 OSTEONECROSIS OF JAW 4 0.0002
795 LIMB DISCOMFORT 5 0.0002
796 FEMUR FRACTURE 5 0.0002
797 INFLUENZA 18 0.0002
798 CYST 2 0.0002
799 LEUKOPENIA 8 0.0002
800 INTENTIONAL PRODUCT MISUSE 14 0.0002
801 ABDOMINAL PAIN LOWER 4 0.0002
802 RENAL FAILURE 21 0.0002
803 GASTRIC ULCER 3 0.0002
804 FEELING JITTERY 3 0.0002
805 ANAEMIA 30 0.0002
806 INJECTION SITE IRRITATION 2 0.0002
807 BURNING SENSATION 11 0.0002
808 HYPOTHYROIDISM 5 0.0002
809 HEPATITIS 4 0.0002
810 DRUG PRESCRIBING ERROR 3 0.0002
811 HIP FRACTURE 5 0.0002
812 HYPERHIDROSIS 20 0.0002
813 ANOREXIA 2 0.0002
814 ANAPHYLACTIC SHOCK 4 0.0002
815 INJECTION SITE INDURATION 2 0.0002
816 PALPITATIONS 18 0.0002
817 ORAL HERPES 3 0.0002
818 BONE PAIN 9 0.0002
819 APPLICATION SITE ERYTHEMA 4 0.0002
820 THROMBOCYTOPENIA 17 0.0002
821 ANKYLOSING SPONDYLITIS 2 0.0002
822 BLOOD PRESSURE ABNORMAL 3 0.0002
823 UPPER LIMB FRACTURE 3 0.0002
824 ACUTE KIDNEY INJURY 23 0.0002
825 URINARY RETENTION 5 0.0001
826 SPINAL FRACTURE 3 0.0001
827 HOSPITALISATION 23 0.0001
828 EMOTIONAL DISTRESS 18 0.0001
829 BLOOD BILIRUBIN INCREASED 4 0.0001
830 NEUTROPHIL COUNT DECREASED 6 0.0001
831 DRUG TOXICITY 2 0.0001
832 CHEST DISCOMFORT 15 0.0001
833 GINGIVAL BLEEDING 2 0.0001
834 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
835 BLOOD GLUCOSE DECREASED 7 0.0001
836 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
837 DIABETES MELLITUS 11 0.0001
838 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
839 HEART RATE DECREASED 5 0.0001
840 HALLUCINATION, VISUAL 3 0.0001
841 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
842 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
843 EATING DISORDER 3 0.0001
844 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
845 INTENTIONAL DOSE OMISSION 4 0.0001
846 CARDIOGENIC SHOCK 2 0.0001
847 ANOSMIA 2 0.0001
848 HYPOKINESIA 2 0.0001
849 PRODUCT DISPENSING ERROR 3 0.0001
850 FLUID RETENTION 7 0.0001
851 FLUID OVERLOAD 2 0.0001
852 PANIC ATTACK 5 0.0001
853 URINARY INCONTINENCE 4 0.0001
854 RASH MACULO-PAPULAR 3 0.0001
855 RENAL INJURY 4 0.0001
856 COLON CANCER 2 0.0001
857 NERVOUSNESS 7 0.0001
858 HEART RATE IRREGULAR 3 0.0001
859 HYPOAESTHESIA ORAL 2 0.0001
860 APHASIA 4 0.0001
861 UNEVALUABLE EVENT 10 0.0001
862 ECONOMIC PROBLEM 2 0.0001
863 PRODUCT AVAILABILITY ISSUE 3 0.0001
864 DEVICE FAILURE 2 0.0001
865 DRUG DISPENSING ERROR 2 0.0001
866 MUSCLE TWITCHING 3 0.0001
867 HAEMATOCHEZIA 7 0.0001
868 PULMONARY EMBOLISM 12 0.0001
869 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
870 ABSCESS 2 0.0001
871 LOSS OF CONSCIOUSNESS 16 0.0001
872 LOCALISED INFECTION 3 0.0001
873 MYALGIA 21 0.0001
874 DEVICE BREAKAGE 5 0.0001
875 CHOLELITHIASIS 4 0.0001
876 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
877 CYTOMEGALOVIRUS INFECTION 2 0.0001
878 DRUG INTERACTION 19 0.0001
879 WITHDRAWAL SYNDROME 5 0.0001
880 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
881 FACE OEDEMA 2 0.0001
882 NEUTROPENIA 16 0.0001
883 HYPOPHAGIA 3 0.0001
884 FEELING ABNORMAL 28 0.0001
885 INJECTION SITE REACTION 8 0.0001
886 HYPOACUSIS 5 0.0001
887 SEPTIC SHOCK 5 0.0001
888 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
889 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
890 LYMPHADENOPATHY 4 0.0001
891 INJECTION SITE ERYTHEMA 14 0.0001
892 DEHYDRATION 15 0.0001
893 GALLBLADDER DISORDER 2 0.0001
894 CARDIAC FAILURE CONGESTIVE 9 0.0001
895 FEAR 3 0.0001
896 GASTROENTERITIS VIRAL 2 0.0001
897 PNEUMONITIS 3 0.0001
898 CRYING 4 0.0001
899 BONE DISORDER 2 0.0001
900 ABNORMAL DREAMS 3 0.0001
901 BLOOD GLUCOSE ABNORMAL 2 0.0001
902 PANCYTOPENIA 6 0.0001
903 HYPONATRAEMIA 6 0.0001
904 BLOOD GLUCOSE INCREASED 20 0.0001
905 COLITIS 4 0.0001
906 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
907 INCREASED APPETITE 2 0.0001
908 NEEDLE ISSUE 3 0.0001
909 PLASMA CELL MYELOMA 4 0.0001
910 INJECTION SITE BRUISING 8 0.0001
911 BLOOD POTASSIUM DECREASED 3 0.0001
912 PSORIASIS 13 0.0001
913 THROMBOSIS 8 0.0001
914 BONE MARROW FAILURE 2 0.0001
915 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
916 INTENTIONAL DRUG MISUSE 2 0.0001
917 JOINT INJURY 2 0.0001
918 MOVEMENT DISORDER 3 0.0001
919 DEVICE LEAKAGE 4 0.0001
920 MENTAL DISORDER 4 0.0001
921 INJECTION SITE SWELLING 7 0.0001
922 STAPHYLOCOCCAL INFECTION 3 0.0001
923 ANAPHYLACTIC REACTION 5 0.0001
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
925 LIP SWELLING 3 0.0001
926 FUNGAL INFECTION 3 0.0001
927 NEOPLASM MALIGNANT 6 0.0001
928 SOMNOLENCE 18 0.0001
929 FLUSHING 9 0.0001
930 APPLICATION SITE PRURITUS 2 0.0001
931 INCORRECT DOSE ADMINISTERED 20 0.0001
932 SKIN IRRITATION 4 0.0001
933 RENAL DISORDER 4 0.0001
934 COGNITIVE DISORDER 4 0.0001
935 DRUG DOSE OMISSION 14 0.0001
936 DISEASE RECURRENCE 4 0.0001
937 IRRITABILITY 5 0.0001
938 PLEURAL EFFUSION 5 0.0001
939 AGITATION 6 0.0001
940 INJECTION SITE URTICARIA 2 0.0001
941 ENCEPHALOPATHY 2 0.0001
942 ABASIA 2 0.0001
943 SYNCOPE 8 0.0001
944 HYPOTENSION 16 0.0001
945 INTESTINAL OBSTRUCTION 3 0.0001
946 TREMOR 13 0.0001
947 DEEP VEIN THROMBOSIS 5 0.0001
948 SUICIDAL IDEATION 7 0.0001
949 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
950 BRADYCARDIA 4 0.0001
951 CARDIAC DISORDER 7 0.0001
952 DEATH 64 0.0001
953 DISTURBANCE IN ATTENTION 4 0.0001
954 LUNG NEOPLASM MALIGNANT 3 0.0001
955 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
956 FEELING COLD 2 0.0001
957 INJECTION SITE PAIN 22 0.0001
958 RENAL FAILURE ACUTE 3 0.0001
959 DYSSTASIA 2 0.0001
960 ASCITES 2 0.0001
961 DISEASE PROGRESSION 8 0.0001
962 DRUG ADMINISTRATION ERROR 2 0.0001
963 EMOTIONAL DISORDER 2 0.0001
964 BONE DENSITY DECREASED 2 0.0001
965 HYPOGLYCAEMIA 3 0.0001
966 INFLUENZA LIKE ILLNESS 5 0.0001
967 SEIZURE 7 0.0001
968 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
969 ANGER 2 0.0001
970 HAEMATURIA 2 0.0001
971 MYOCARDIAL INFARCTION 10 0.0001
972 PRODUCT STORAGE ERROR 5 0.0001
973 SKIN BURNING SENSATION 4 0.0001
974 DRUG EFFECT INCOMPLETE 2 0.0001
975 RESPIRATORY FAILURE 4 0.0001
976 DYSURIA 2 0.0001
977 DYSARTHRIA 2 0.0001
978 ABORTION SPONTANEOUS 2 0.0000
979 EXTRA DOSE ADMINISTERED 2 0.0000
980 DYSKINESIA 2 0.0000
981 INJECTION SITE PRURITUS 3 0.0000
982 DEVICE ISSUE 4 0.0000
983 DRUG EFFECT DECREASED 2 0.0000
984 CARDIAC ARREST 3 0.0000
985 CONVULSION 2 0.0000
986 OVERDOSE 7 0.0000
987 DEVICE DIFFICULT TO USE 2 0.0000
988 TOXICITY TO VARIOUS AGENTS 5 0.0000
989 HAEMORRHAGE 3 0.0000
990 DEVICE MALFUNCTION 2 0.0000
991 INJECTION SITE HAEMORRHAGE 2 0.0000
992 DRUG WITHDRAWAL SYNDROME 2 0.0000